Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors

類似資料

• Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors
  著者:: Caroline D. Binde, 等
  出版事項: (2021-01-01)
• Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
  著者:: Binde, Caroline D., 等
  出版事項: (2020)
• Neuroprotection of MAO-B inhibitor and dopamine agonist in Parkinson disease
  著者:: Kong, Ping, 等
  出版事項: (2015)
• Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
  著者:: Krishna, Rakhee, 等
  出版事項: (2014)
• Effects of a Dopamine Agonist on the Pharmacodynamics of Levodopa in Parkinson Disease
  著者:: Brodsky, Matthew A., 等
  出版事項: (2010)